Literature DB >> 23270429

An N-terminally truncated mutant of human chemokine CXCL14 has biological activity.

José L Neira1, María J Sandí, Julio Bacarizo, Cendrine Archange, Ana Camara-Artigas, Juan L Iovanna.   

Abstract

Chemokines are members of the superfamily of cytokines involved in: (i) cell migration to sites of infection; or (ii) cellular stress during an immune response. Human CXCL14/BRAK is a monocyte-selective chemokine expressed in all normal tissues, but is also involved in the development of several cancers. We describe the expression, structural characterization and biological activity of an N-terminal truncated mutant of CXCL14, ΔCXCL14, where the first eleven residues and the two disulphide bridges were removed. We designed this species in order to analyse the biological importance of the disulphide bonds and the flexible N terminus of CXCL14 for its protein folding, stability and function. The mutant ΔCXCL14 is biologically active, as suggested by the in vitro assays with migration of pancreatic cancer cells, but also its structure is not well-fixed, as suggested by fluorescence, CD and NMR. We conclude that the disulphide bridges are important in maintaining the structure of this chemokine, but they are not necessary for the biological activity of CXCL14 species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23270429     DOI: 10.2174/09298665113209990040

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  2 in total

1.  RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.

Authors:  Zili Zhang; Mei Guo; Yujia Li; Min Shen; Desong Kong; Jiangjuan Shao; Hai Ding; Shanzhong Tan; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Autophagy       Date:  2019-11-11       Impact factor: 16.016

2.  Deciphering the binding between Nupr1 and MSL1 and their DNA-repairing activity.

Authors:  David Aguado-Llera; Tewfik Hamidi; Rosa Doménech; David Pantoja-Uceda; Meritxell Gironella; Jorge Santoro; Adrián Velázquez-Campoy; José L Neira; Juan L Iovanna
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.